Stockreport

Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024 [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF Posters to be Presented by Dr. Li Zhang and Dr. Jack West on Friday, March 22 in Prague MIAMI, March 14, 2024 BUSINESS WIRE )--Summit Therapeutics Inc. (NASDAQ: SMMT) [Read more]